768dkk
-6,6 %
Date:2025-04-02Time:17:20:00Latest report:Q4-2024List:First NorthTicker:VIRO
Market Cap:59 mdkkEnterprise Value:53 mdkkNet Sales:4,90 mdkkEarnings:-14,3 mdkkEmployees:0ISIN:DK0061030574

Ratios

10-year key figure history for ViroGates turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for ViroGates with index and moving average MA50 and MA200.

Stockprice:7,68
MA50:9,90
MA200:9,07
Price/MA200:-15,3 %
RSI (14):42,8
Price/MA50:-22,5 %

Description

ViroGates AS is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

Medical Equipment